12 Medical 获得 $45M B 轮融资，用于阻塞性睡眠呼吸暂停的神经调控治疗。 12 Medical secures $45M Series B funding for neuromodulation therapy for obstructive sleep apnea.
12 Medical 获得由 Omega Funds 和 Intuitive Ventures 领投的 4500 万美元 B 轮融资，用于推进阻塞性睡眠呼吸暂停的神经调控疗法，帮助全球 4.25 亿人。 12 Medical secures $45M Series B funding led by Omega Funds and Intuitive Ventures to advance neuromodulation therapy for obstructive sleep apnea, aiding 425 million people globally. 这些资金将用于临床研究和产品开发,重点是简化治疗、扩大获得治疗的机会和解决病人的合规问题。 The funds will be used for clinical research and product development, focusing on simplifying therapy, expanding access, and addressing patient compliance issues. 该公司成立于2017年,旨在改进治疗结果,并与主要合作伙伴合作促进技术进步。 Founded in 2017, the company aims to improve treatment outcomes and collaborate with leading partners for technology advancement.